Senores Pharmaceuticals Ltd. IPO

listed · BSE and NSE · Bookbuilding IPO

Senores Pharmaceuticals Ltd. IPO was a book-built issue on BSE and NSE with a price band of ₹372–₹391 per share, open for bidding from 20 Dec 2024 to 24 Dec 2024.

Last updated: · How we collect data

Company overview

Website
https://senorespharma.com/

IPO overview

The issue was a book-built issue, combining new shares issued by the company (a fresh issue) with shares sold by existing shareholders (an offer for sale).

Bids were accepted within a price band of ₹372–₹391 per share (face value ₹10); the final issue price is set within this band after bidding closes.

Applications were made in lots of 38 shares, so one lot costs ₹14,858 at the upper end of the price band.

The shares listed on BSE and NSE on 30 Dec 2024.

Equirus Capital Ltd. was the book-running lead manager.

Promoters held 66.67% of the company before the issue.

Issue type
Bookbuilding IPO
Issue structure
Fresh capital cum OFS
Price
₹372–₹391 per share
Lot size
38 shares
Minimum investment (1 lot)
₹14,858
Face value
₹10 per share
Exchange
BSE and NSE
Lead manager
Equirus Capital Ltd.

IPO timeline

  1. Bidding opens 20 Dec 2024
  2. Bidding closes 24 Dec 2024
  3. Basis of allotment —
  4. Refunds / unblocking —
  5. Shares credited to demat —
  6. Listing 30 Dec 2024

Bidding ran from 20 Dec 2024 to 24 Dec 2024.

The shares listed on 30 Dec 2024.

Sources and data methodology

NSE & BSE public-issue data; Chittorgarh and InvestorGain (fill gaps only). Methodology · Report an error

Tools

IPOs around the same time

Related guides